Expression of Dlk1 gene in myelodysplastic syndrome determined by microarray, and its effects on leukemia cells

International Journal of Molecular Medicine

Volumn 22, Issue 1, 2008, Pages 61-68

  Qi, Xiaofei ^a   Chen, Zixing ^a   Liu, Dandan ^a   Cen, Jiannong ^a   Gu, Ming ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

Cell proliferation; Delta like 1; Microarray; Myelodysplastic syndrome; Real time polymerase chain reaction

Indexed keywords

ARSENIC TRIOXIDE; DELTA LIKE PROTEIN 1; MEMBRANE PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN DLK 1; TRANSCRIPTION FACTOR HES 1; UNCLASSIFIED DRUG; CD34 ANTIGEN; DLK1 PROTEIN, HUMAN; ORGANOARSENIC DERIVATIVE; OXIDE; SIGNAL PEPTIDE;

APOPTOSIS; ARTICLE; CD34 SELECTION; CELL CYCLE; CELL PROLIFERATION; CELL STRAIN K 562; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMIA CELL; MICROARRAY ANALYSIS; MONONUCLEAR CELL; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; ADULT; AGED; DNA MICROARRAY; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; GENETICS; LEUKEMIA; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; ANTIGENS, CD34; APOPTOSIS; ARSENICALS; CELL CYCLE; CELL PROLIFERATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; K562 CELLS; LEUKEMIA; LEUKOCYTES, MONONUCLEAR; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDES; TETRADECANOYLPHORBOL ACETATE; UP-REGULATION;

EID: 52049103360     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijmm.22.1.61     Document Type: Article

References (22)

1. Heaney ML and Golde DW: Myelodysplasia. N Engl J Med 340: 1649-1660, 1999.
2. Gardais J: Dyshaemopoiesis in adults: a practical classification for diagnosis and management. Leuk Res 8: 641-651, 2000.
3. Bennett JM: World Health Organization classification of the acute leukemias and myelodysplastic syndrome. Int J Hematol 72: 131-133, 2000.
4. Oosterveld M, Wittebol SH, Lernmens WA, et al: The impact of intensive antileukaemic treatment strategies on prognosis of myelodysplastic syndrome patients aged less than 61 years according to International Prognostic Scoring System risk groups. Br J Haematol 123: 81-89, 2003.
5. + cells from patients with myelodysplastic syndrome characterized by specific chromosomal abnormalities. Blood 104: 4210-4218, 2004.
6. Miyazato A, Ueno S, Ohmine K, et al: Identification of myelodysplastic syndrome-specific genes by DNA microarray analysis with purified hematopoietic stem cell fraction. Blood 98: 422-427, 2001.
7. + cells from normal and myelodysplastic bone marrow. Blood 100: 3553-3560, 2002.
8. Langer F, Stickel J and Tessema M: Overexpression of delta-like (Dlk) in a subset of myelodysplastic syndrome bone marrow trephines. Leuk Res 28: 1081-1083, 2004.
9. Schmidt JV, Matteson PG, Jones BK, et al: The Dlk1 and Gtl2 genes are linked and reciprocally imprinted. Genes Dev 14: 1997-2002, 2000.
10. Laborda J: The role of the epidermal growth factor-like protein dlk in cell differentiation. Histol Histopathol 15: 119-129, 2000.
11. Samulewicz SJ, Seitz A, Clark L and Heber-Katz E: Expression of preadipocyte factor-1 (Pref-1), a delta-like protein, in healing mouse ears. Wound Repair Regen 10: 215-221, 2002.
12. Moore KA, Pytowski B, Witte L, et al: Hematopoietic activity of a stromal cell transmembrane protein containing epidermal growth factor-like repeat motifs. Proc Natl Acad Sci USA 94: 4011-4016, 1997.
13. Ohno N, Izawa A, Hattori M, et al: Dlk inhibits stem cell factor-induced colony formation of murine hematopoietic progenitors: Hes- 1 -independent effect. Stem Cells 19: 71-79, 2001.
14. Bauer SR, Ruiz-Hidalgo MJ, Rudikoff EK, et al: Modulated expression of the epidermal growth factor-like homeotic protein dlk influences stromal-cell-pre-B -cell interactions, stromal cell adipogenesis, and pre-B-cell interleukin-7 requirements. Mol Cell Biol 18: 5247-5255, 1998.
15. Kaneta M, Osawa M, Sudo K, Nakauchi H, et al: A role for Pref-1 and HES-1 in thymocyte development. J Immunol 164: 256-264, 2000.
16. Li L, Forman SJ and Bhatia R: Expression of DLK1 in hematopoietic cells results in inhibition of differentiation and proliferation. Oncogene 24: 4472-4476, 2005.
17. Sakajiri S, O'Kelly J, Yin D, et al: Dlk1 in normal and abnormal hematopoiesis. Leukemia 19: 1404-1410, 2005.
18. Fang G, Kim CN, Perkins CL, et al: CGP57148B (STI-571) induces differentiation and apoptosis and sensitizes Bcr-Abl-positive human leukemia cells to apoptosis due to antileukemic drugs. Blood 96: 2246-2253, 2000.
19. Qian J, Chen Z, Wang W, et al: Gene expression profiling of the bone marrow mononuclear cells from patients with myelodysplastic syndrome. Oncol Rep 14: 1189-1197, 2005.
20. Qian J, Chen Z, Lin J, et al: Decreased expression of CCAAT/ enhancer binding protein (C/EBP) in patients with different myeloid disease. Leuk Res 29: 1435-1441, 2005.
21. Kim JW, Kim MJ, Kim KJ, et al: Notch interferes with the scaffold function of JNK-interacting protein 1 to inhibit the JNK signaling pathway. Proc Natl Acad Sci USA 102: 14308-14313, 2005.
22. Haruki N, Kawaguchi KS, Eichenberger S, et al: Dominant-negative Notch3 receptor inhibits mitogen-activated protein kinase pathway and the growth of human lung cancers. Cancer Res 65: 3555-3561, 2005.